Workplace drug testing has long been a vital tool for Norfolk employers looking to protect their staff, maintain productivity, and comply with health and safety regulations. Most Norfolk businesses rely on standard drug test panels that screen for well-known substances such as Cannabis, Cocaine, and Opiates. But new research suggests there may be a blind spot in many UK companies drug testing policies — one that could leave employers exposed to rising risks.
An increasingly popular drug among young people is slipping under the radar of standard workplace testing. Not only is its use on the rise, but reports also show it is now being used to bulk out more expensive substances like Cocaine and MDMA. This means many users don’t even realise they’ve taken it, making the risks in workplace environments even harder to manage. The effects include impaired judgement, slower reaction times, and disorientation — all of which can pose serious safety issues, particularly in industries involving machinery, driving, or manual work.
For employers, the implications are clear: failing to your drug testing policy could mean missing a substance that directly impacts staff wellbeing, workplace safety, and overall performance. Businesses employing younger demographics or operating in safety-critical roles are especially advised to review their drug screening policies.
Comprehensive drug testing kits that include emerging substances are already available, including ultra-sensitive drug test kit panels designed to give employers full peace of mind. Taking proactive steps now could protect your business from costly accidents, absenteeism, or compliance issues in the future.
?Learn more about the dangerous drug employers might be missing in workplace drug testing on our UK drug testing news page to learn what every employer should know about this latest emerging workplace challenge.